Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)

Davide Maggi, Fabrizio Montecucco, Gianfranco Adami, Renzo Cordera

Research output: Contribution to journalArticle

Abstract

Despite intensive research, therapy of diabetes mellitus type 2 (T2DM) is far from be effective. The most important unresolved issue is to establish a safe glycosylated hemoglobin C (A1c) value well balanced between benefit and side effects. As a result different guidelines suggest different A1c targets generating confusion for patients and clinicians. Here we report two observations which might support a relaxed A1c as suggested by American college of physician (ACP).

Original languageEnglish
Article number48
JournalDiabetology and Metabolic Syndrome
Volume11
Issue number1
DOIs
Publication statusPublished - Jun 20 2019

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)'. Together they form a unique fingerprint.

  • Cite this